Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Gavin P Robertson

Showing results (81-90 of 111) with videos related to

Pageof 12
Sort By:
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 12, 2009
Targeting Akt3 signaling in malignant melanoma using isoselenocyanatesArati Sharma, Arun K Sharma, Subbarao V Madhunapantula, et al.
Cancer Prevention Research (Philadelphia, Pa.)|November 25, 2010
Melanoma chemoprevention in skin reconstructs and mouse xenografts using isoselenocyanate-4Natalie Nguyen, Arati Sharma, Nhung Nguyen, et al.
Cancer Biology & Therapy|August 31, 2017
Identification of WEE1 as a target to make AKT inhibition more effective in melanomaOmer F Kuzu, Raghavendra Gowda, Arati Sharma, et al.
Journal of the National Cancer Institute|July 28, 2010
KLF6 Gene and early melanoma development in a collagen I-rich extracellular environmentSung Jin Huh, Yen-Liang Chen, Scott L Friedman, et al.
Cancer Letters|July 15, 2017
Improving pharmacological targeting of AKT in melanomaOmer F Kuzu, Raghavendra Gowda, Arati Sharma, et al.
Cancer Research|February 11, 2011
eEF-2 kinase dictates cross-talk between autophagy and apoptosis induced by Akt Inhibition, thereby modulating cytotoxicity of novel Akt inhibitor MK-2206Yan Cheng, Xingcong Ren, Yi Zhang, et al.
Nature Communications|February 5, 2025
Modification of the telomerase gene with human regulatory sequences resets mouse telomeres to human lengthFan Zhang, De Cheng, Kenneth I Porter, et al.
Experimental Parasitology|May 19, 2015
A non-cytotoxic N-dehydroabietylamine derivative with potent antimalarial activityMaralinganadoddi P Sadashiva, Raghavendra Gowda, Xianzhu Wu, et al.
Cancer Research|October 7, 2004
Deregulated Akt3 activity promotes development of malignant melanomaJill M Stahl, Arati Sharma, Mitchell Cheung, et al.
Pharmacological Research|March 17, 2025
Managing telomerase and telomere dysfunction in acral melanomaVishnu Sravan Bollu, Yu-Chi Chen, Fan Zhang, et al.
Pageof 12

Showing results (81-90 of 111) with videos related to

Sort By:
Pageof 12
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 12, 2009
Targeting Akt3 signaling in malignant melanoma using isoselenocyanatesArati Sharma, Arun K Sharma, Subbarao V Madhunapantula, et al.
Cancer Prevention Research (Philadelphia, Pa.)|November 25, 2010
Melanoma chemoprevention in skin reconstructs and mouse xenografts using isoselenocyanate-4Natalie Nguyen, Arati Sharma, Nhung Nguyen, et al.
Cancer Biology & Therapy|August 31, 2017
Identification of WEE1 as a target to make AKT inhibition more effective in melanomaOmer F Kuzu, Raghavendra Gowda, Arati Sharma, et al.
Journal of the National Cancer Institute|July 28, 2010
KLF6 Gene and early melanoma development in a collagen I-rich extracellular environmentSung Jin Huh, Yen-Liang Chen, Scott L Friedman, et al.
Cancer Letters|July 15, 2017
Improving pharmacological targeting of AKT in melanomaOmer F Kuzu, Raghavendra Gowda, Arati Sharma, et al.
Cancer Research|February 11, 2011
eEF-2 kinase dictates cross-talk between autophagy and apoptosis induced by Akt Inhibition, thereby modulating cytotoxicity of novel Akt inhibitor MK-2206Yan Cheng, Xingcong Ren, Yi Zhang, et al.
Nature Communications|February 5, 2025
Modification of the telomerase gene with human regulatory sequences resets mouse telomeres to human lengthFan Zhang, De Cheng, Kenneth I Porter, et al.
Experimental Parasitology|May 19, 2015
A non-cytotoxic N-dehydroabietylamine derivative with potent antimalarial activityMaralinganadoddi P Sadashiva, Raghavendra Gowda, Xianzhu Wu, et al.
Cancer Research|October 7, 2004
Deregulated Akt3 activity promotes development of malignant melanomaJill M Stahl, Arati Sharma, Mitchell Cheung, et al.
Pharmacological Research|March 17, 2025
Managing telomerase and telomere dysfunction in acral melanomaVishnu Sravan Bollu, Yu-Chi Chen, Fan Zhang, et al.
Pageof 12